Nina Tandon

Nina Tandon, co-founder and CEO of EpiBone, has demonstrated her expertise in the biotechnology industry through her innovative approach to skeletal repair. EpiBone, under Tandon's leadership, has made significant strides in the medical field by growing customized human bones from patients' cells. The company's technology includes a proprietary bioreactor that mimics human body conditions to grow bones ready for implantation within three weeks. This pioneering technology won FDA approval in 2023 for testing lab-grown bones in humans.

In addition to her role at EpiBone, Tandon is recognized for her contributions to academia. She is an adjunct professor of Electrical Engineering at Cooper Union and a senior fellow at the Lab for Stem Cells and Tissue Engineering at Columbia. Her previous role as an associate postdoctoral researcher for the Stem Cells and Tissue Engineering Laboratory at Columbia University, as well as her holding of three patents, underscore her deep understanding of the intersection between technology and biology.

Throughout her career, Tandon has been honored by a number of prestigious organizations. She was named a TED Fellow in 2011 and a Senior TED Fellow in 2012, with several TED talks to her credit. Fast Company included her among its Most Creative People of 2012, and she received Marie Claire's Women on Top Awards in 2013. Further recognition includes being named a Wired innovation fellow, a 2015 Global Thinker by Foreign Policy, and part of Crains New York's 40 Under 40 Class of 2015. Tandon's recognition by L'Oréal Paris as one of its Women of Worth in the science and innovation category further underscores her significant contributions to the field. She is also an advocate for diversity and inclusion in STEM fields.